Enteric diseases are a group of illnesses that affect the gastrointestinal tract, including the stomach and intestines. These diseases are typically caused by infection with bacteria, viruses, or parasites, and can result in symptoms such as diarrhea, vomiting, abdominal pain, and fever. Some common examples of enteric diseases include cholera, typhoid fever, norovirus, and E. coli infections. These diseases can be spread through contaminated food or water, or through contact with infected individuals or animals. Enteric diseases can be particularly dangerous for young children, the elderly, and people with weakened immune systems.
Allied Market Research has published a study report with the title Enteric Disease Testing Market Size was Valued at USD 3.8 Billion in 2022 and is Projected to Garner USD 5.3 billion by 2032, registering a CAGR of 3.3% from 2023 to 2032. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
ππ‘ππ ππ«π ππ‘π πππππ¨π«π¬ ππ«π’π―π’π§π ππ‘π ππ§πππ«π’π ππ’π¬πππ¬π πππ¬ππ’π§π πππ«π€ππ?
Increase in awareness in developing countries regarding diagnosis of infectious enteric diseases, easy availability of testing reagents of enteric disease, and technological advancement in testing equipment of enteric diseases drive the growth of the global enteric disease testing market. However, the high cost associated with molecular diagnostic assay is hampering the enteric disease testing market growth. On the contrary, the increase in adoption of key strategies by key players is expected to offer remunerative opportunities for expansion of the enteric disease testing market during the forecast period.
Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/295
ππ¨π© ππ§πππ«π’π ππ’π¬πππ¬π πππ¬ππ’π§π ππ¨π¦π©ππ§π’ππ¬
β’ Abbott Laboratories
β’ Becton Dickinson & Company
β’ Biomerica Inc.
β’ Biomerieux SA
β’ Bio-Rad Laboratories Inc.
β’ Coris Bioconcept
β’ Diasorin S.p.A.
β’ Meridian Bioscience Inc
β’ Quest Diagnostics
β’ Trinity
ππ§πππ«π’π ππ’π¬πππ¬π πππ¬ππ’π§π πππ«π€ππ ππ’π³π πππ π¦ππ§ππππ’π¨π§: β
Based on product type, the reagents and consumables segment held the highest market share in 2022, accounting for more than two-thirds of the global enteric disease testing market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to rise in number of market players who manufactures reagents and consumables and increase in awareness among people regarding use of kits for diagnosis of enteric disease.
Based on technique, the immunodiagnostics segment held the highest market share in 2022, accounting for more than three-fifths of the global enteric disease testing market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to high adoption of immunodiagnostics technique and increase in technological advancement in immunodiagnostic technique.
Based on end user, the hospital laboratories segment held the highest market share in terms of revenue in 2022, accounting for around four-fifths of the global enteric disease testing market revenue, and is estimated to maintain its leadership status throughout the forecast period.
Based on region, North America held the highest market share in terms of revenue in 2022, accounting for nearly two-fifths of the global enteric disease testing market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to robust healthcare infrastructure, presence of key players, and rise in healthcare expenditure. However, the Asia-Pacific region is expected to witness the fastest CAGR of 5.2% from 2023 to 2032, owing to an increase in awareness related to use of enteric disease testing products, unmet medical demands, and high population base.
Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/295
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
By Region Outlook
β’ North America
(U.S., Canada, Mexico)
β’ Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
β’ Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
β’ LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of βMarket Research Reportsβ and βBusiness Intelligence Solutions.β AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.